bi 54903
Small moleculeexperimental
Clinical trial activity
10 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
6
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2008 (NCT02221375)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bi54903
- bi 54903
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01458912 | Phase 2 | Nov 1, 2011 | Boehringer Ingelheim |
| NCT01458886 | Phase 2 | Nov 1, 2011 | Boehringer Ingelheim |
| NCT01428622 | Phase 2 | Oct 1, 2011 | Boehringer Ingelheim |
| NCT01396278 | Phase 2 | Jul 1, 2011 | Boehringer Ingelheim |
| NCT01397162 | Phase 2 | Jul 1, 2011 | Boehringer Ingelheim |
| NCT01397201 | Phase 2 | Jul 1, 2011 | Boehringer Ingelheim |
| NCT01309139 | Phase 1 | Mar 1, 2011 | Boehringer Ingelheim |
| NCT02222428 | Phase 1 | Apr 1, 2009 | Boehringer Ingelheim |
| NCT02220660 | Phase 1 | Mar 1, 2009 | Boehringer Ingelheim |
| NCT02221375 | Phase 1 | Jun 1, 2008 | Boehringer Ingelheim |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 10 | 10 | 2 | 2008 |
1 organizations
Page 1 / 1